secwatch.observer — SEC 8-K summary
======================================

Issuer:     Streamex Corp. (STEX)
CIK:        0001530766
Form:       8-K
Filed at:   2025-04-15T23:59:59+00:00
Accession:  0001641172-25-004850
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioSig Technologies receives Nasdaq bid-price deficiency notice; 180-day cure period until Oct 8, 2025
--------------------------------------------------------------------------------

- On April 11, 2025, Nasdaq notified BioSig that its common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 calendar days (until October 8, 2025) to regain compliance by closing at $1.00 or more for at least 10 consecutive days.
- If not cured by October 8, may seek an additional 180-day extension by meeting other listing standards and signaling intent to reverse split.
- Failure to regain compliance could lead to delisting from Nasdaq Capital Market; no immediate impact on trading.
- Stock continues to trade under symbol BSGM while the company addresses the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530766/000164117225004850/0001641172-25-004850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530766/000164117225004850/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-004850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer